E
Waverley Pharma Inc. WAVE.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Very Weak
Risk Grade E+
Reward Grade E
Rating Factors WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Very Weak
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Beta -1.06
Price History WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 0.00%
30-Day Total Return 0.00%
60-Day Total Return -33.33%
90-Day Total Return -50.00%
Year to Date Total Return -33.33%
1-Year Total Return -71.43%
2-Year Total Return -75.00%
3-Year Total Return -83.33%
5-Year Total Return -84.62%
52-Week High % Change -71.43%
52-Week Low % Change 0.00%
Price WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $0.04
52-Week Low Price $0.01
52-Week Low Price (Date) Aug 23, 2024
52-Week High Price (Date) Apr 17, 2024
Valuation WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 380.93K
Enterprise Value 2.30M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.04
Earnings Per Share Growth 73.33%
Price/Earnings To Growth --
Price/Sales (TTM) 11.11
Price/Book (Q) -0.36
Enterprise Value/Revenue (TTM) 44.07
Price $0.01
Enterprise Value/EBITDA (TTM) -3.24
Enterprise Value/EBIT -2.59
Market Cap Category Nano Cap
Dividends and Shares WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 54.00M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 204 928 7907
Address 4-1250 Waverley Street Winnipeg, MB R3T 6C6
Website www.waverleypharma.com
Country Canada
Year Founded 2014
Profitability WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -1,702.10%
Profit Margin -3,119.15%
Management Effectiveness WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -39.24%
Return on Equity --
Income Statement WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 52.20K
Total Revenue (TTM) 52.20K
Revenue Per Share $0.00
Gross Profit (TTM) -25.20K
EBITDA (TTM) -710.10K
EBIT (TTM) -888.50K
Net Income (TTM) -1.63M
Net Income Avl. to Common (TTM) -1.63M
Total Revenue Growth (Q YOY) -77.09%
Earnings Growth (Q YOY) 13.41%
EPS Diluted (TTM) -0.04
EPS Diluted Growth (Q YOY) 2.67%
Balance Sheet WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 177.10K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 351.20K
Total Preferred Equity (Q) --
Total Equity (Q) -1.49M
Current Ratio (Q) 0.132
Book Value Per Share (Q) -$0.03
Total Assets (Q) 1.32M
Total Current Liabilities (Q) 2.65M
Total Debt (Q) 2.19M
Total Liabilities (Q) 2.81M
Total Common Equity (Q) -1.49M
Cash Flow WAVE.V - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -448.50K
Cash from Financing (TTM) 1.19M
Net Change in Cash (TTM) 152.40K
Levered Free Cash Flow (TTM) -435.80K
Cash from Operations (TTM) -586.40K
Weiss Ratings